ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

SBTX Skinbiotherapeutics Plc

9.25
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Skinbiotherapeutics Plc LSE:SBTX London Ordinary Share GB00BF33H870 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 9.25 9.00 9.50 9.25 9.25 9.25 59,297 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 132k -2.84M -0.0163 -5.67 16.1M
Skinbiotherapeutics Plc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker SBTX. The last closing price for Skinbiotherapeutics was 9.25p. Over the last year, Skinbiotherapeutics shares have traded in a share price range of 7.25p to 29.50p.

Skinbiotherapeutics currently has 174,004,323 shares in issue. The market capitalisation of Skinbiotherapeutics is £16.10 million. Skinbiotherapeutics has a price to earnings ratio (PE ratio) of -5.67.

Skinbiotherapeutics Share Discussion Threads

Showing 1276 to 1298 of 23575 messages
Chat Pages: Latest  55  54  53  52  51  50  49  48  47  46  45  44  Older
DateSubjectAuthorDiscuss
06/2/2018
10:41
Buying at 8.2p! Had to grab a few more.
jestercat2
06/2/2018
10:26
ps .. didn't mean to sound patronizing there
onedayrodders
06/2/2018
09:08
Dr.Cath will be promoting the business at four events between later this month and early March prior to the human trials of the cosmetic cream.

Perhaps more news releases coming our way soon imo. SBTX is a gift at these discounted prices.

bobalot
06/2/2018
08:55
Crazy over-reaction. Just bought 31K at 8.2p! My lowest purchase price of SBTX.
parob
01/2/2018
15:42
These events and publications are worth tracking:

Dr. Cath is a speaker at the European event being held in Holland: Microbiome R&D and Business Collaboration Forum: Europe 21st-22nd Mar 2018.




Microbiome Futures is a landmark event that will document the future of microbiome research and commercialisation.

A half day panel discussion – reporting on KOL research and audience consultation

250 participants from leading companies and institutions
Outcomes to be published in Nature Biotechnology
Gala networking dinner

The live event, on May 23, will be the culmination of a thorough research process during which the working group will be gathering input from a global pool of stakeholders in the microbiome space. They will come prepared, having researched and discussed issues from the science of moving from correlation to causation to practical solutions to data and regulatory hurdles.

bobalot
01/2/2018
06:44
Cath is well known to several global players as she has researched and tested for boots and j and j I believe.

I'm terry sure they are being kept in the loop on progress.

Cap way too low for me.

Just needs volume so happy to buy when it's quiet when funds allow.

shrewdmole
01/2/2018
06:42
The organisers of the conference said:"Following the mainstream focus on the gut microbiome and its role in health and disease, researchers and industry experts are now turning their attention towards the emerging relationship between the skin microbiome and healthy skin. This has the potential to revolutionise the beauty and personal care industry,"
parob
31/1/2018
22:13
Interest building in the sector. Think this is the first conference I’ve seen specifically for the skin microbiome sector:

Skin Microbiome Conference set for May 2018

31-Jan-2018

parob
31/1/2018
12:27
Shook the piggy bank and just grabbed 35k at 8.75p. Great price.
zedder
30/1/2018
19:00
From their twitter:Company CEO Cath O'Neill is to present at the Shares Investor Evenings in Manchester (20 Feb 2018) and Edinburgh (28 Feb 2018) where she'll be talking about SkinBioTherapeutics' history and strategy for 2018.It was a company presentation that ignited the N4P share price. Hopefully the same will happen here!!
parob
30/1/2018
18:44
Thanks Bobalot - wasn't aware of that - reassuring!
jestercat2
30/1/2018
17:05
The next news will come from a presentation from SBTX towards the end of February where Dr. Cath/ CEO will explain the schedule going forward...so clearly the schedule has changed and is probably going to be accelerated by bringing developments forward.

THUS NOTHING TO FEAR -- this is a better investment than most that is highly likely to give excellent returns for investors.

bobalot
30/1/2018
15:55
Bobalot - is that the next 'expected' news? All gone rather quiet here. Is there anything else likely in the pipeline before May? If not I fear for the share price in the meantime.
jestercat2
30/1/2018
13:20
SkinBio is not far behind the commercialization curve for its cosmetic cream because human testing starts Q2/2018 -- possibly April and if it provides proof of purpose the commercial partner who has been showing interest since last September is highly likely to use the SkinBio product.

The Human Trials will only take a month followed by assessment. We could get all the results and analysis in by mid May imo.

It is worth noting the cosmetic cream has already been tested on live skin during development.

There are about three major players in the market so far including SBTX so its still early doors for what will become a massive market change for the cosmetics industry.

bobalot
30/1/2018
10:52
Interesting article. I like how it talks to skin microbiome being on trend for 2018. But it also looks a like a decent competitor on the cosmetics front. It also talks to applying their science to acne and eczema, similar to SBTX plans. On the downside they clearly have a headstart and now have Unilever backing. Cosmetics will be all about the marketing to get the attention followed by user experience of the product. It will be interesting to see how SBTX product is marketed. Getting a big player to sell and market will also determine success. Looking at Gallinée website they tell a nice story. But as you say, the attractive message here is that other big players will be looking to get into the skin microbiome trend!
toadhall1
30/1/2018
08:03
Another nibble for me whilst it's under the IPO price.

Some of the biggest global companies are now moving into this space.

Unilever Ventures takes minority stake in microbiome beauty start-up Gallinée


29/1/18

parob
26/1/2018
23:16
I've had him on filter for ages, after his n'enth meaningless post.
He must like talking to himself??

Anyway, just wanted to say, nice weather in Surrey, while we wait for any interesting news.
John

2350220
26/1/2018
16:26
Here is the latest edition of the magazine:



Well worth a read imo.

bobalot
26/1/2018
16:23
Here is a very interesting sector development.

Researchers Discover 10 New Immune Systems in Bacteria
The findings more than double the number of known defense mechanisms, piquing the interests of molecular biology tool developers.

By Jim Daley | January 25, 2018

bobalot
26/1/2018
13:49
Now that's a thought owenmo,
I wonder if SoH's team might develop microbiome for treating OCD !!
John

2350220
26/1/2018
12:21
elrico 25 Jan '18 - 15:47 - 1265 of 1268 (Filtered)

WHAT AN IDIOT AND WHAT A RAMPER.

bobalot
25/1/2018
18:57
Obsessive compulsive disorder (OCD) - in three little words.
owenmo
25/1/2018
16:42
I see what you me, all posted several times before and by the same hand. The joys of spare time. :(
incanus
Chat Pages: Latest  55  54  53  52  51  50  49  48  47  46  45  44  Older

Your Recent History

Delayed Upgrade Clock